Gendel Limited
Crescent Capital Initial Investment 2000
Crescent Capital made its initial investment in this business in March 2000 when the technology was still at a preliminary stage. The company raised a second round of £2m in January 2002.
Gendel is a research company currently based in an incubator unit on the University of Ulster’s Coleraine campus. Crescent Capital was part of a syndicate of 3 VC’s who invested originally and Scottish Equity Partners came on board in the second round.
The business was established as a spin out company to develop a new targeted drug delivery system based on early research carried out in the University of Ulster. It has made advances in methods of loading red blood cells with specific chemicals and in sensitising these cells so that they will release their loads in response to an ultrasound stimulus. The technology could have major implications for the use of certain drugs by avoiding side effects and increasing the concentration of the actives at the required site within the body.
More recently, the company has also been investigating the treatment of Cancer tissues using electrical stimulation.
Contact Details
Crescent Contact : Deirdre Terrins
Science Business Incubator Centre
Cromore Road
Coleraine, BT52 1RF
Tel: +44 (0) 28 7032 3101
Fax: +44 (0) 28 7032 3102
http://www.gendel.co.uk
Crescent Capital NI Ltd is authorised and regulated by the Financial Services Authority
Crescent Capital NI Ltd is a member of the EVCA